Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00024635 |
Recruitment Status :
Recruiting
First Posted : April 29, 2005
Last Update Posted : May 23, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Mood Disorders Anxiety Disorders Healthy Volunteers Bipolar Disorder Depression |
Study Type : | Observational |
Estimated Enrollment : | 16000 participants |
Observational Model: | Cohort |
Time Perspective: | Other |
Official Title: | The Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers |
Actual Study Start Date : | February 2, 2001 |

Group/Cohort |
---|
Adult Healthy Volunteers
Adult Healthy Volunteers
|
Adult Patients
Adult patients with mood and anxiety disorders
|
Minor Healthy Volunteers
Minor Healthy Volunteers
|
Minor Patients
Minor patients with mood and anxiety disorders
|
Parents of Minor Healthy Volunteers
Parents and guardians of minor healthy volunteers
|
Parents of Minor Patients
Parents and guardians of minor patients with mood and anxiety disorders
|
- Eligibility for research [ Time Frame: Current and historical ]Evaluations of psychiatric and other medical conditions and histories to determine if the subjects are appropriate for participation in NIMH IRB approved protocols and for the collection of natural history data.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 3 Years to 99 Years (Child, Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
- INCLUSION CRITERIA:
Subjects ages 3 to 99 may enroll in the protocol.
Subjects must be competent to comprehend the purpose of the screening process and to provide written informed consent and be willing to participate in NIMH IRB approved research protocols. Minors will be asked to assent and their parents will sign the consent form.
Subjects will undergo an evaluation which may include a psychiatric interview, medical (including Tanner staging for minors), neurological, and laboratory examinations (as appropriate such as EKG, EEG, renal and liver function tests, serum electrolytes, urinalysis, HIV, hepatitis A, B, and C, blood levels of psychotropic drugs, pregnancy testing, and urine drug screen for the presence of psychoactive drugs and drugs of abuse).
EXCLUSION CRITERIA:
Subjects should have no general medical illness that is primary (i.e., appears to be causing the mood disorder or anxiety disorder).
Current alcohol or substance use or dependence (excluding nicotine) of sufficient magnitude to require independent, concurrent treatment intervention (e.g., antabuse or opiate treatment, but not including self-help groups).
Whether the minor lives with both parents or one parent, the parent(s) he/she lives with must have legal custody. If a parent has shared custody, both parents must consent to participate in this protocol.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00024635
Contact: Carlos A Zarate, M.D. | (877) 646-3644 | moodresearch@mail.nih.gov |
United States, Maryland | |
National Institutes of Health Clinical Center | Recruiting |
Bethesda, Maryland, United States, 20892 |
Principal Investigator: | Carlos A Zarate, M.D. | National Institute of Mental Health (NIMH) |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | National Institute of Mental Health (NIMH) |
ClinicalTrials.gov Identifier: | NCT00024635 |
Other Study ID Numbers: |
010254 01-M-0254 |
First Posted: | April 29, 2005 Key Record Dates |
Last Update Posted: | May 23, 2023 |
Last Verified: | April 13, 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Plan Description: | .During the screening process, if a clinical issue arises that warrants further evaluation and/or possible treatment, the subject will be informed and advised to seek medical care in the appropriate setting outside of NIH. |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Screening Anxiety Mood Diagnostic Testing Natural History |
Disease Anxiety Disorders Bipolar Disorder Mood Disorders |
Pathologic Processes Mental Disorders Bipolar and Related Disorders |